Dr. Fenton has served as a member of our Board of Directors since November 2011. Dr. Fenton, now retired, was most recently executive vice president for operations and compliance at Amgen, Inc. Dr. Fenton worked at Amgen, Inc., for over two decades from 1982 to 2008, serving in roles such as senior vice president of operations, senior vice president of sales, marketing and process development, and vice president of process development, facilities, and clinical manufacturing. Prior to joining Amgen, Inc., Dr. Fenton served as senior research scientist at Pfizer, Inc., and previously was a research associate and graduate student at Rutgers University. Dr. Fenton received his bachelor’s degree from Manhattan College of New York and his doctorate of philosophy from Rutgers University of New Jersey. He is currently a member of the Board of Directors for Genelux Corporation, Napo Pharmaceuticals, Inc., Kythera Biopharmaceuticals, Inc., and XenoPort, Inc.